Galectin Therapeutics shares owned by Traynor Capital Management
Quarter-by-quarter ownership of Galectin Therapeutics (GALT) shares owned by Traynor Capital Management
from 13F filings
Historical chart of Traynor Capital Management investment in Galectin Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Galectin Therapeutics held by Traynor Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Galectin Therapeutics by Traynor Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $420k | 99k | 4.24 |
| 2025-06-30 | $218k | 98k | 2.22 |
| 2025-03-31 | $94k | 77k | 1.22 |
| 2024-12-31 | $72k | 56k | 1.29 |
| 2024-09-30 | $118k | 43k | 2.75 |
| 2024-06-30 | $97k | 43k | 2.26 |
| 2024-03-31 | $83k | 35k | 2.39 |
| 2023-12-31 | $58k | 35k | 1.66 |
| 2023-09-30 | $67k | 35k | 1.92 |
More positions owned by Traynor Capital Management
View all positions for Traynor Capital Management